Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-10-12Clinical Trial Update: Phase II Open Label Multicenter Study For Age Related Macular Degeneration Comparing PF-04523655 Versus Lucentis In The Treatment Of Subjects With CNV (MONET Study). [Phase 2]
Phase II open-label, multicenter trial (MONET) completed comparing PF-04523655 to Lucentis for neovascular age-related macular degeneration …
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD) [Phase 1]
Phase 1 trial update of PF-04523655 (REDD14NP) in patients with choroidal neovascularization secondary to wet age-related macular degenerati…
-
CLINICAL_TRIALS trial_result · 2012-09-27Clinical Trial Update: Combined Therapy in Age-Related Macular Degeneration (ARMD) [Phase 4]
This report notes the completion of a Phase 4 clinical trial evaluating a combined therapy for age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Phase I Study of Palomid 529 a Dual TORC1/2 Inhibitor of the PI3K/Akt/mTOR Pathway for Advanced Neovascular Age-Related Macular Degeneration [Phase 1]
Phase I study of Palomid 529, a dual TORC1/2 inhibitor of the PI3K/Akt/mTOR pathway, for advanced neovascular age-related macular degenerati…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Low Vision Study Comparing EV Training vs. CCTV for AMD Rehabilitation [Phase 2]
Phase 2 trial comparing EV training to CCTV for rehabilitation in age-related macular degeneration has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular Degeneration [Phase 2]
Phase 2 trial evaluating dexamethasone as adjunctive therapy to ranibizumab for choroidal neovascularization in age-related macular degenera…
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD) [Phase 2]
Phase 2 trial evaluating an adjunctive therapy to anti-VEGF for wet age-related macular degeneration. The study has completed and results we…
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD) [Phase 2]
Phase 2 trial update evaluating a new adjunctive therapy to anti-VEGF for age-related macular degeneration; study completed with results pos…
-
CLINICAL_TRIALS research · 2012-08-31Clinical Trial Update: Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD) [NA]
This document reports an update on a clinical trial investigating how genetic polymorphisms influence ranibizumab treatment in wet age-relat…
-
CLINICAL_TRIALS trial_result · 2012-08-30Clinical Trial Update: Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial [Phase 3]
A Phase 3 trial comparing Lucentis (ranibizumab) and Avastin (bevacizumab) for age-related macular degeneration has completed with results p…
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab Dosing [Phase 4]
Phase 4 trial updates the recurrence rate of wet age-related macular degeneration in patients stabilized on three-month dosing with ranibizu…
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of Lucentis [Phase 4]
A Phase 4 clinical trial update evaluating changes in optical coherence tomography parameters after intravitreal Lucentis (ranibizumab) inje…
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD [Phase 1]
Phase 1 trial comparing safety of CGC-11047 given every 2 weeks vs every 4 weeks in patients with CNV due to Age-related macular degeneratio…
-
CLINICAL_TRIALS research · 2012-08-02Clinical Trial Update: VEGF Gene Association With Response to Neovascular Age-related Macular Degeneration With Anti-VEGF Agents
A clinical trial update examines whether VEGF gene variation influences response to anti-VEGF therapy in neovascular age-related macular deg…
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Foresee Home for Monitoring Age Related Macular Degeneration (AMD)
Update on the Foresee Home monitoring trial for age-related macular degeneration; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Effects of Xanthophylls on Optical Density [NA]
A completed clinical trial from the University of Jena evaluating the effects of xanthophylls on optical density in age-related macular dege…
-
CLINICAL_TRIALS trial_result · 2012-07-23Clinical Trial Update: Evaluation of Optical Coherence Tomography.
A completed clinical trial evaluating Optical Coherence Tomography in Age-related Macular Degeneration.
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation on Optical Density of AMD Patients (LUTEGA) [NA]
The LUTEGA trial evaluated the long-term effects of lutein/zeaxanthin and omega-3 supplementation on optical density in patients with age-re…
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: Photodynamic and Pharmacologic Treatment of CNV [Phase 1, Phase 2]
This clinical trial update notes the completion of Phase 1 and Phase 2 studies investigating photodynamic and pharmacologic approaches to tr…
-
FDA approval · 2012-06-28FDA Approved: VISUDYNE — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for VISUDYNE (verteporfin for injection) submitted by Bausch & Lomb Incorporated. The action updates…
-
CLINICAL_TRIALS research · 2012-06-22Clinical Trial Update: Effect of Intravitreal Anti-VEGF on Retinal Vessels Diameter [NA]
An ongoing clinical trial investigates how intravitreal anti-VEGF treatment affects retinal vessel diameter in age-related macular degenerat…
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: Long-term Follow-up of Subfoveal Neovascular AMD
This document provides a long-term follow-up update from a clinical trial investigating treatments for exudative age-related macular degener…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Efficacy of Electrical Micro-current Retinal Stimulation for Treatment of Dry Age-related Macular Degeneration [Phase 1, Phase 2]
Phase 1/2 trial evaluating electrical micro-current retinal stimulation for dry age-related macular degeneration reports efficacy outcomes.
-
CLINICAL_TRIALS withdrawal · 2012-05-10Clinical Trial Update: Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration (AMD) [NA]
A pilot trial evaluating reduced-fluence photodynamic therapy with Visudyne plus ranibizumab versus ranibizumab alone for exudative age-rela…
-
CLINICAL_TRIALS trial_result · 2012-05-01Clinical Trial Update: Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration [Phase 1]
Phase 1 trial of intravitreal LFG316 in patients with age-related macular degeneration has completed.